Previous 10 | Next 10 |
home / stock / elv / elv articles
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 8.36% on an annualized basis producing an average annual return of...
Cigna Group (NYSE: CI) and Humana Inc (NYSE: HUM) are reportedly discussing a merger deal to create a new powerhouse in the health i...
Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years by 7.71% on an annualized basis producing an average annual return of...
Elevance Health (NYSE:ELV) has outperformed the market over the past 20 years by 6.78% on an annualized basis producing an average annual return of...
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 9.25% on an annualized basis producing an average annual return of...
Elevance Health Inc (NYSE: ELV) has reported Q3 FY23 adjusted EPS of $8.99, up 20.5% Y/Y, beating the consensus of $8.45. Operating reven...
Elevance Health (NYSE:ELV) has outperformed the market over the past 20 years by 6.1% on an annualized basis producing an average annual return of ...
As the U.S. launches a fresh round of updated COVID-19 vaccines, some patients encounter hurdles in obtaining prompt health insurance coverage...
Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years by 7.0% on an annualized basis producing an average annual return of ...
News, Short Squeeze, Breakout and More Instantly...
Elevance Health Inc Com Company Name:
ELV Stock Symbol:
NYSE Market:
Elevance Health Inc Com Website:
2024-07-17 12:00:27 ET Image source: The Motley Fool. Elevance Health (NYSE: ELV) Q2 2024 Earnings Call Jul 17, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Elevance Health (ELV) Q2 2024 Earnings Call Transcript
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...